Use of Levetiracetam in Epileptic Dogs with Chronic Kidney Disease: A Retrospective Study
In human medicine, doses of levetiracetam (LEV) are individualized for patients with epilepsy, depending on the status of the patient’s renal function. However, there are not reports on the individualized dosing of LEV for small animals. The aim of this study is to investigate whether a dose adjustm...
Main Authors: | So-Yeon Gim, Woo-Jin Song, Hwa-Young Youn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/8/11/263 |
Similar Items
-
Levetiracetam induced behavioral changes: a case report
by: R. Kamalraj, et al.
Published: (2018-12-01) -
Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
by: Ekaterina I. Viteva, et al.
Published: (2021-04-01) -
Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
by: Rui Silva, et al.
Published: (2022-08-01) -
Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
by: Sandra R. P. Kriechbaumer, et al.
Published: (2022-07-01) -
Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)